Human anti-IL-23 antibodies, compositions, methods and uses

Details for Australian Patent Application No. 2012238198 (hide)

Owner Janssen Biotech Inc.

Inventors Benson, Jacqueline; Carton, Jill; Cunningham, Mark; Orlovsky, Yevgeniya I.; Rauchenberger, Robert; Sweet, Raymond

Agent Shelston IP

Pub. Number AU-A-2012238198

Parent 2006330411

Filing date 4 October 2012

Wipo publication date 25 October 2012

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/567 Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

25 October 2012 Application Open to Public Inspection

  Published as AU-A-2012238198

25 October 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012238199-Anti-IL-6 antibodies, compositions, methods and uses

2012238197-Activin-ActRIIa antagonists and uses for promoting bone growth